| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Frazier Life Sciences Viii, L.P. is a 10% Owner at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $233.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2023 | ARQT Arcutis Biotherapeutics, Inc. | 10% Owner | Buy | 80,000 | $2.50 | $200,000.00 | +0.9% | +48.1% | +249.4% | |
| Aug 5, 2022 | ARQT Arcutis Biotherapeutics, Inc. | 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +3.0% | -28.9% | -60.9% | |
| Feb 4, 2020 | ARQT Arcutis Biotherapeutics, Inc. | 10% Owner | Buy | 500,000 | $17.00 | $8,500,000.00 | +5.0% | - | - |